Maternal antibodies block malaria.
M Fried, F Nosten, A Brockman...
https://pubmed.ncbi.nlm.nih.gov/9804416Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-06-01
15000
Participants Needed
2
Research Sites
N/A
Total Duration
Malaria caused by Plasmodium falciparum remains a major global health issue with serious consequences. This research aims to better understand the immune and parasite factors related to infection and disease during pregnancy and early childhood. The study focuses on how pregnancy malaria affects birth outcomes like low birth weight and maternal anemia, and explores how childhood malaria risk may be influenced by exposure before birth and other factors such as iron levels and immune responses. Researchers also investigate whether parasites causing severe childhood malaria have unique characteristics. The study enrolls up to 2000 pregnant women and their newborns, and 2000 children aged 0 to 3 years, who will be followed until age 5. Additionally, 3000 febrile children up to age 10 are recruited from health centers and hospitals for acute and recovery assessments. A separate case-control study includes 500 pregnant women to explore malaria and preeclampsia. Up to 1000 children from the initial birth cohort may be followed for up to 10 years into adolescence and early adulthood. Participants undergo clinical exams and provide periodic blood samples over these periods. Participants will be monitored through clinical evaluations and blood sample collections to analyze parasite presence, immune responses, and host factors. The main outcome is to identify maternal, placental, parasite, and host factors linked to resistance or susceptibility to malaria infection and disease in children up to 5 years old. The study uses careful statistical analysis to understand these associations. Participation may last from birth up to 10 years, with ongoing assessments to track health and malaria outcomes.
CONDITIONS
Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years for infants and children
Participants are observed with clinical evaluation and periodic blood samples to study malaria infection and disease during pregnancy and early childhood.
Periodic visits for clinical evaluation and blood sample collection
Duration - Up to 10 years
Children originally enrolled at birth and completing the initial study are re-enrolled and followed through later childhood, adolescence, and early adulthood to monitor malaria-related outcomes.
Periodic visits depending on age and study schedule
Total: 2 locations
1
Gabriel Toure Hospital
Bamako, Mali
Actively Recruiting
2
Ouelessebougou Clinical Research Center
Wolossébougou, Mali
Actively Recruiting
M
Michal Fried, Ph.D.
P
Patrick E Duffy, M.D.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
M Fried, F Nosten, A Brockman...
https://pubmed.ncbi.nlm.nih.gov/9804416M Ho, B Singh, S Looareesuwan...
https://pubmed.ncbi.nlm.nih.gov/1997437Atis Muehlenbachs, Theonest K Mutabingwa, Sally Edmonds...
https://pubmed.ncbi.nlm.nih.gov/17105340Justin Y A Doritchamou, Jonathan P Renn, Bethany Jenkins...
https://pubmed.ncbi.nlm.nih.gov/35103596Almahamoudou Mahamar, Patricia A Gonzales Hurtado, Robert Morrison...
https://pubmed.ncbi.nlm.nih.gov/34871370Almahamoudou Mahamar, Naissem Andemel, Bruce Swihart...
https://pubmed.ncbi.nlm.nih.gov/33846719Michal Fried, Jonathan D Kurtis, Bruce Swihart...
https://pubmed.ncbi.nlm.nih.gov/29020221